Skip to main content
. Author manuscript; available in PMC: 2024 Oct 24.
Published in final edited form as: Brain Behav Immun. 2023 Dec 22;116:269–285. doi: 10.1016/j.bbi.2023.12.025

Fig. 2.

Fig. 2.

Conditional ablation of microglial TNFR2 does not affect functional measurements after ischemic stroke and spinal cord injury. (A-B) Quantification of side-specific and total grip strength in female (A) and male (B) Cx3cr1CreER:Tnfrsf1bfl/fl mice and Tnfrsf1bfl/fl littermates at day 1 post-pMCAO (females: n = 9/group; males: n = 10/group). (C-D) Quantification of right and left paw withdrawal latency during the Hargreaves test in female (C) and male (D) Cx3cr1CreER:Tnfrsf1bfl/fl mice and Tnfrsf1bfl/fl littermates at day 3 and 5 post-pMCAO (females: n = 10–14/group; males: n = 5–9/group). (E) Quantification of the clinical score and subscore according to the Basso mouse scale (BMS) in female Cx3cr1CreER:Tnfrsf1bfl/fl mice and Tnfrsf1bfl/fl littermates over time after SCI (score: n = 16–17/group; subscore: n = 6–7/group), bw: body weight.